Monthly Archives: July 2012

Foundation for Fighting Blindness Chapter Meeting Please join us on Saturday, October 3, 2009 at 10:00 a.m. for a presentation by Rajendra Kumar-Singh, Ph.D., Associate Professor of Ophthalmology and Neuroscience, Tufts University School of Medicine, New England Eye Center. Meet other people who are affected by retinal diseases, hear about upcoming chapter activities, and see… Read More

New Treatment Found to Reduce Vision Loss from Central Retinal Vein Occlusion Eye injections of corticosteroid medication may improve patients’ vision FOR IMMEDIATE RELEASE Caroline Baumal, MD Boston, MA. September 15, 2009 – New England Eye Center is pleased to announce that Scientists have identified the first long-term, effective treatment to improve vision and reduce… Read More

Laser Treatment for Vision Loss from Branch Retinal Vein Occlusion is Safer than Corticosteroid Injections Study shows that Laser Treatment is both safer and equally effective FOR IMMEDIATE RELEASE Boston, MA. September 15, 2009 – New England Eye Center is pleased to announce that Scientists have found that laser therapy is equivalent to two different… Read More

FOR IMMEDIATE RELEASE BOSTON, MA SEPTEMBER 15, 2009 – New England Eye Center (NEEC, the Ophthalmology Department of Tufts Medical Center) has acquired Pediatric and Adult Ophthalmic Associates of Framingham owned by Richard J. Blocker, MD and the recently retired Edward Miller, MD. The practice will continue much as before the name changed on September… Read More

Get ready for an innovation in lashes. LATISSE® (bimatoprost ophthalmic solution) 0.03% is the first and only prescription treatment approved by the FDA for inadequate or not having enough eyelashes, growing them longer, fuller and darker. Become a fan of our Facebook page. A lot of great information and Videos on Latisse.

The crystalens® is an accommodative IOL (intraocular lens) that presents an exciting vision correction option for patients with cataracts. Like traditional IOLs used in cataract surgery, the crystalens® is used to replace a patient’s natural, cloudy lens. However, what makes the crystalens® unique is that it is the first accommodating IOL that allows patients to… Read More

What are your options? The standard option… The Alcon ACRYSOF® Single-piece Monofocal IOL provides clear distant vision. This means that you will be able to see objects that are far away, but will most likely need reading glasses for near vision. The standard monofocal IOL has been successfully implanted in millions of cataract patients who… Read More

How the eye works Light enters the eye through the cornea (the clear front window of the eye). The amount of light that enters is controlled by the pupil. In people with perfect vision, the light focuses directly on the retina and the image is sent to the brain. In many people with vision problems,… Read More

If you have presbyopia and are unsuitable for other procedures, our surgeons may suggest producing monovision. To produce monovision, the dominant eye is focused for distance vision, and the non-dominant eye is focused for near vision. This means that the farsighted eye will do most of the work when looking at objects far away, and… Read More

For more information, videos and details: http://visianinfo.com/cwc/_premium/index.php?siteid=1214 One of the latest IOLs to be approved by the FDA is the Visian ICL™ by STAAR Surgical. The Visian ICL™ is a posterior chamber phakic intraocular lens. In other words, the lens is placed behind the iris, where it is practically invisible. The Visian ICL™ is made… Read More